View online Forward to a friend   |   Facebook   |   Twitter
Pharmaceutical Outsourcing
Featured Articles   |   Featured Partners   |   Videos   |   Industry News   |   Events
June 09, 2020
learn more
Newsletter Sponsor
   Acquisition Adds Injectable and Otic Dose Form Technologies

Adare has recently acquired Orbis Biosciences. The acquisition will expand Adare’s expertise in taste-masking and controlled release technology platforms. Orbis provides enhanced technologies in a scaled, single-step manufacturing process. The Precision Particle Fabrication® platform technology is flexible and customizable to accommodate a broad range of active ingredients, including small molecules, peptides and proteins. Orbis’s proprietary technology includes three platforms: Optimµm® , for oral delivery; Stratµm™, for injectable delivery; and Unisun®, for otic delivery.

more info

» Industry News
 
more news
» Featured Articles
COVID-19 Increases Pressure on Pharma to Get Things Right
There’s no doubt the COVID-19 pandemic has heightened everyone’s concern about safety. read more »
Overcoming Study-Patient Burdens in Medical Research During the Pandemic
Study-patient recruitment and retention continue to be significant challenges in medical research, and even more so, during the COVID-19 pandemic. The at-home isolation and social distancing orders ... read more »
more articles
 
» Featured Partners
learn more
  Maximize Your Injectable Molecule in 2020

Looking to maximize your injectable molecule manufacturing? Backed by over 85 years of Baxter parenteral expertise, BioPharma Solutions offers a wide variety of contract manufacturing solutions across multiple drug categories. read more »
» Featured Video
learn more
  On-Demand Webinar: Novel ADC Conjugates: Characterization Tools and Formulation/Process Development
In this webinar you will learn: ADC analytical characterization techniques and current regulatory expectations Alternative approaches to quantitate ADC DAR. Optimizing bench-scale conjugation. read more »
learn more
  Watch Webinar: From DNA Sequence to GMP Manufacturing
From DNA Sequence to GMP Manufacturing read more »

more videos
 
» Featured Whitepaper
Opioid Reformulation for Abuse Deterrence
While prescription opioids are necessary for pain management, opioid abuse is an ongoing public health emergency. read more »
Support of Scale-Up and Technical Transfer Through Understanding Equipment for Lyophilization
Formulation and process development for injectable products are typically conducted at laboratory-scale. There are few challenges when increasing the ... read more »
more articles
 
| Events
EVENT
  CPhI North America
Philadelphia, PA –  09/09/2020
Over the last three years, CPhI North America has brought together more than 15,000 industry professionals across the entire pharmaceutical supply ... event details »
EVENT
  Pre-Filled Syringes East Coast 2020
Virtual –  10/26/2020
The global pre-filled syringes market was valued at $4.9 billion in 2018 and with the rapid growth of the industry, is expected to exceed $9.7 billion... event details »
more events
This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact Pharmaceutical Outsourcing


Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA